BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Oct. 6, 2010
View Archived Issues
One GIANT Step for Mankind: New Genes for Height Control
Read More
Agennix Nets $105M in Share Offer to Develop Talactoferrin
Read More
GW Testing Cannabinoids in Diabetes, Metabolic Syndrome
Read More
'Father of 4 Million' Wins Medicine Nobel for IVF Work
Read More
Other News To Note
Read More
Zealand's Lixisenatide Hits Mark in Phase III Combo Trial
Lixisenatide, the Type II diabetes molecule discovered by Zealand Pharma A/S, met the primary endpoint in the first Phase III combination trial. (BioWorld International)
Read More
GlaxoSmithKline Spins Out Firm with Ion Channel Portfolio
Read More